ETON.O (ETON.O) News
Follow ETON.O (ETON.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BRIEF — Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million — SEC Filing
Oct 14 (Reuters) — Eton Pharmaceuticals Inc: Eton Pharmaceuticals - Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - Sec Filing Eton Pharmaceuticals - To Pay Aquestive Up To $47.50 Million In Miles
CENTRAL_BANK | Oct 14, 2026, 12:20 PM UTC
L
BUZZ — Aquestive rises on US licensing deal for seizure drug with Eton Pharma
* Aquestive Therapeutics shares gain 4.3% to $4.87 premarket * The drugmaker says it licensed exclusive US rights to its Libervant to Eton Pharmaceuticals * The seizure treatment is expected to launch in April 2027, subj
REGULATION | Oct 14, 2026, 12:04 PM UTC
L
Eton Pharmaceuticals signs exclusive US license deal with Aquestive for Libervant seizure rescue film
Eton Pharmaceuticals signed an exclusive U.S. license and supply deal with Aquestive for LIBERVANT (diazepam) buccal film for seizure clusters. Eton targets an April 2027 commercial launch, contingent on final FDA approv
REGULATION | Oct 14, 2026, 10:50 AM UTC